Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:investor
|
| gptkbp:assetsUnderManagement |
over $7 billion
|
| gptkbp:businessModel |
private
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:foundedYear |
2007
|
| gptkbp:founder |
gptkb:Barry_Siadat
gptkb:Jamshid_Keynejad |
| gptkbp:headquartersLocation |
gptkb:New_York_City
|
| https://www.w3.org/2000/01/rdf-schema#label |
SK Capital Partners
|
| gptkbp:industry |
private equity
investment management |
| gptkbp:investedIn |
pharmaceuticals
chemicals specialty materials |
| gptkbp:notableInvestment |
gptkb:SI_Group
gptkb:Ascend_Performance_Materials gptkb:Archroma gptkb:ICIG_(International_Chemical_Investors_Group) gptkb:Noramco gptkb:Perimeter_Solutions gptkb:Wavelength_Pharmaceuticals |
| gptkbp:numberOfEmployees |
over 50
|
| gptkbp:website |
https://www.skcapitalpartners.com/
|
| gptkbp:bfsParent |
gptkb:SI_Group
|
| gptkbp:bfsLayer |
6
|